Cargando…
Corporations, high-stakes biomedical research, and research misconduct: yes they can (and sometimes do)
Science has long been vulnerable to research misconduct (RM). Biomedical sciences, with vast financial stakes, carry heightened temptations. However, RM is standardly seen as an undertaking of individual scientists, not as something that could be committed by an organization such as a corporation or...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247552/ https://www.ncbi.nlm.nih.gov/pubmed/34221435 http://dx.doi.org/10.1093/jlb/lsab014 |